HopeStage
Back to all studies
CompletedNCT05870501

Brain connections and ketamine research in resistant depression

About this titleRead the official source — NCT05870501
Medication studyAges 18–55United Kingdom
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
LondonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 20, 2021
Recruitment status
Completed
Enrollment listed in the registry
56
Sponsor
King's College London
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United Kingdom
Age range
From 18 Years to 55 Years
Official registry ID
NCT05870501
Official title
Show the full official title

Synaptic Imaging and Brain Network Activity Following Ketamine in Treatment Resistant Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is King's College London, a university.

Did this study involve medication?

Yes. The study involved medication, including ketamine and Midazolam.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies